NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email The Financial Conduct Authority has launched a stablecoin cohort as part of its Regulatory Sandbox. Participating firms will be able to help shape UK crypto rules. A major firm has already signed on, says FCA executive.Read More